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Differentiation between malignant
melanomas and benign melanocytic nevi by
computerized DNA cytometry of imprint
specimens*
Recently image analysis (IA) and DNA-cytophotonieti-)' (CP)
have proved to be tiseltil for the diflerentiaticin between be-
nign and malignant melanocytic lesions on paraffin sections.
Since, on sections, these procedmes are veiy time-consmning,
we t.ested in the present study whether IA of imprint speci-
mens, which can be evahiated in less than 30 minutes, might
also be stifllcient. In 39 malignant melanomas (MM), 18 mela-
nocytic nevi (MN), and 6 dysplastic nevi (DN), 12 different
morphometric and DNA cytonietric feattires wet'e determined
in 100 randomly selected nuclei, ln tmivariate analysis, 5 fea-
tures were found to be significantly difierent between the be-
nign and malignant groups (p<0.0001): mean value (MAREA)
and standard deviation (SARFA) of nuclear area and the 80lh,
90th, and 95th peicentiles ol' DNA distribution. Using SAREA,
the best univariate feature, 82.5% of ihe cases could be cc:)r-
rectly separated. In mnltivariale analysis wilh a combination of
three I'eatures - standard deviation of unclear area (SAREA),
mean DNA value (MDNA), and 95th percentile of DNA distri-
bution (PERC95) - a correct diagnosis was achieved in 89.5%
of the cases. Results obtained in ihe cases of DN indicated an
increased proliferation, btit did not allow the separation of DN
from MM and MN. Since our (ecluiic]iie allows a rapid analysis
withottt loss of tisstie, which might be important for histolog-
ical analysis, and the classification rates are equal or still
higher than reported in studies on sectic^ms, imprints of mela-
nocytic lesions seem to be most a|)propriale for the calculation
of DNA cytometric featvires as helpful diagnostic criteria in
equivocal melanocytic lesions.
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The histologic differential diagnosis between pri-
mary malignant melanoma (MM) and benign mel-
anocytic nevi (MN) can be difficttlt, which might
be due to the lack of generally accepted and ade-
quate reproducible criteria (1-3) as shown espe-
cially in the .survey of Jones (1). In that stttdy,
experts in dermatopathology were asked to delin-
eate their five most important criteria for diagnosis
of MM (1). Fifty distinct criteria were mentioned
by 48 histopathologists, demonstrating consider-
able heterogeneity and controversy. Cytologic aty-
pia was the most frequently mentioned criterion.
However, also cytologic atypia is not clearly de-
fined and can be related to cellular size, nuclear
size and shape, as well as to nucleolar morphology.
Also in an international pathologists congruence
survey, an overall consistency in determining hist-
ological features in MM of cjnly 70% was reported
(4). Despite this discrepancy, in the majority of the
ca.ses the diagnosis rendered by a dermatopathol-
ogist based on years of accumulated experience is
highly reliable.
To obtain more precise and c^bjective diagnostic
criteria, several laboratory techniqttes have been
applied, e.g. morphometry (5-7), monoclonal an-
tibody labeling (8-10), cell culture studies (II) ,
chromosome analysis (12-14) and, due to the sig-
nificance of DNA for diagnosis of various human
neoplasms (15), DNA measurements (16 - 21).
The latter can be performed by How cytometi7
(FC) (22), cytopholometi-y (CP) (23), or by image
analysis (IA) .systems (24). The diagnostic effi-
ciency of FC strongly varied in the sttidies per-
formed Ibr discrimination between MM and MN
from 52.8% to 100% with a mean value of 74.5%
(25-30). This discrepancy might be due to the
difficulty in FC to recognize a small number of
anetiploid cells among background activity. Also
atitofluorescence of melanocytes and stroma cells
may disturb data analysis as indicated by Newton et
al. (31). In contrast to FC, efficiency of IA and CP
for discrimination of MM and MN was found to be
higher (16, 17, 29, 32-35), ranging from 76.1% to
100% with a mean value of 87.5%^ However, DNA
meastirements on sections are more time-constim-
ing because, at least in a part of the nuclei, the
Table t. Diagnoses and patients' characteristics of the 63 cases studied
Diagnosis
melanocytic nevi
dysplastic nevi
SSM
NMM
unclassified MM
metastases
Number
of cases
18
6
19
14
1
5
Age (mean)
(years)
26.6
55.2
52.9
51.6
61,0
60.
Female/
male
12/6
2/4
11/8
5/9
0/1
4/1
exact border has to be determined interactively for
each cell. In addition, fieqtiently entire nuclei are
not completely located within the section, thtis
leading to problems in data analysis. These difficul-
ties can be avoided by tising imprint specimens for
DNA measurements. This offers three main ad-
vantages: a) Dtie to the high contrast between the
nuclei and the background, atitomatic and tliere-
fore rapid segmentation of the nuclear border is
possible, leading to a significant decrea.se of analy-
sis time, b) Bias due to measurements of sectioned
nuclei can be avoided, c) An immediate prepara-
tion after excision of a suspicious lesion is possible
also withotit loss of tissue, which may be required
for subsequent histologic, immunohistologic, and
molecular biologic analyses.
In our hands, imprint specimens proved to be
also very useful in diagnostic and prognostic eval-
uation of cutaneous pseudolympliomas and malig-
nant non-Hodgkin lymphonias (36, 37).
To the best of our knowledge this study demon-
strates for the first time the full benefit of DNA
measurements for the diagnosis of MM on imprint
specimens using a computerized high-iesohition
IA system. Statistical evaluation was performed us-
ing 12 features in a stepwise multivariate discrimi-
nant analy.sis. A diagnostic .sensitivity of 89.7% and
a specificity of 88.9% was attained tising a combina-
tion of three features: Standard deviation of nucle-
ar area (SAREA), mean nuclear DNA content
(MDNA), and 95th percentile of DNA histogram
(PERC95).
iVIateriai and iVIethods
Patients
DNA meastirements were performed on imprint
preparations of skin lesions from 63 patients with
melanocytic lesions. The diagnosis was established
from bistological sections by two independent der-
matopathologists. DNA analysis was performed
withotit knowledge of histpathologic diagnosis. Of
the 63 ca.ses, 18 were clas.sified as MN (2 of junc-
tional type, 10 of compound type, 5 of dermal type,
1 combined nevus), 6 as dysplastic melanocytic
nevi (DN) according to the criteria given by Clark
(.88), 19 as superlicial sprc:-ading MM (SSM) and 14
as nodular MM (NMM). One MM could not be
ftirther classified. In addition, five metastases of
MM were analyzed. Of the melanomas studied
11.8% were of Clark level II, 44.1% of level III,
41.2% of level IV and 2.9% of level V. Tumor
thickness was below 0.75 mm in 32.3%, between
0.76 and 1.5 mm in 32.3% and higher than 3.0 in
8.8% of the cases studied. Mitotic rate per mm^ was
equal to or below 1.0/nim2 in 11.8% of tbe melan-
omas, between 1.01 and 5.0 /min2 in 58.8%, and
DNA cytometry
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Fig. /. Steps for auloniatic (iotcclion of nuclc-ar border of a
melanocytic cell.
a: original video image, b: mapping ol' the acliial grey levels
linearly into the lull range olgrey values, c: aiiplication ol tbe
fnnclion EMPHASE, wliicb performs an addition of die origi-
nal image vvilb die diirerence ol die original image and llie
low-passed filtered version of il. d: deleclion of ihe conlonr of
the nucleus using a grey value tlneshold of l.'M) in image c. e:
smootbing of die contour by applying a dilalalion anrl erosion
subsequently. By (bis step small holes widiin die objecl are
filled. 1: inleiaclivc conlrol of segmenlalion.
higher than 5.0 /mm2 in 29.4% of the tumors. For
detailed data concerning patients, age, and sex,
see Table 1.
Imprints
Imprints were prepared on clean glass slides by
applying the freshly cut stirfece of a skin biopsy.
The imprints were fixed in methanol (100%), for-
maldehyde (37%), and glacial acetic acid (90%)
85:10:5 (V/V/V). Feulgen-staining was performed
according to Bohm (39) with hydrolysis in 5n HCL
for 50 min at 28°(^ and staining in Schiffs reagent
for 60 mill.
DNA measurements
DNA analysis was performed by the high-resolution
image analysis system IPS (Kontron, Eching, Ger-
many). The imprint specimens were digitalized
with a density of 16 pixels/|xm using a TV Pasecon
camera ( Bosch, Stuttgart, Germany) connected with a
100-oil objective of an Axioplan microscope (Zeiss,
Oberkochen, Germany).
Automatic segmentation
In a first step, the contrast within the original video
image (see Fig. la) was increased by mapping the
actual grey levels linearly into the iiill range be-
tween black (grey value 0) and white (grey value
255) (see Fig. lb). The contour of the nuclei was
automatically Ibtind tising the ftinction EMPHASE,
which reproduced an addition of the original im-
age widi the difference of the original image and
the low-pas.sed filtered version of it (Fig. lc). Sub-
seqviently, a constant grey valtie threshold of 130
was tised for the automatic segmentation of the
nuclei (Fig. Id). By applying a dilatation and ero-
sion, the outer contour oi' the nuclei was smoothed
out (Fig. le). In the same step the holes inside
were filled. Inaccurate segmentation could be re-
jected interacuvely, because tbe contour was given
in the overlay of the original image at the end of
the segmentation process (Fig. If).
Parameters calculated
For each nucleus the optical density (OD) and the
area were calculated. The integrated optical den-
sity (IOD) was obtained as the product of the OD
and the area. In Feulgen-stained nticlei the IOD is
linearly correlated with the DNA content (39). In
each slide 20 chicken eiythrocytes were nsed as an
internal reference. In a prexious pilot sttidy a com-
parison of chicken eiythrocytes and normal hu-
man lymphocytes revealed the following relation-
ship: OD,,, X 3.26 = 2cDNA. 2c is the normal DNA
content oi' a hnman cell. A etiploid cell in G2-
phase contains 4cDNA. In this sludy, the relative
DNA content in each of lOO randomly .selected
cells was calculated as follows: relative DNA con-
tent = IOD nucleu.s/IODlcDNA.
Simtiltaueotis analyses of some imprints stained
with May-Criinwald slaining, which allows a clear
differentiation between melanocytic cells and ker-
atinocytes due to both celhilar and nuclear fea-
tures, proved that most of the cells on imprints
were of melanocytic origin. However, a morph-
ologic differentiation of melanocytic cells from
other cells (e.g. keratinocytes) cannot be definitely
performed in Feulgen stained imprints.
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Table 2. Univariafe classification of melanocytic nevi and maiignant meianomas
Variables
SAREA
MAREA
MDNA
SDNA
M2cDi
S2cDI
M2cDIM
S2cDiM
5cER
PERC80
PERC90
PERC95
Meianocytic
Nevi
Mean
16.49
76.33
2.07
0,11
0.10
0.49
0.59
0,16
0,06
2.11
2,16
2.25
SD
4,03
8,89
0.68
0,14
0,09
0.43
1.52
0.39
0.24
0,18
0.08
0.06
Malignant
Melanomas
Mean
28,85
107,44
2.90
0,28
2,53
2,58
3.04
1.23
2.85
3,18
3.49
3.89
SD
7.55
26.95
1.40
0,29
2.16
2.35
4.14
1.84
5.05
1.22
1.13
1.04
F values
42.37*
22.64*
5.67
5,69
14.55
13.97
5.92
5.92
5.44
31.70*
24.67*
18.78*
For explanation of variables, see Material and Methods. Significant F-values for
p< 0,0001 are marked by an asterisk.
Special DNA algorithms for data evaluation
The discriminating power of the following feattires
of the DNA histogram was also evaluated:
Mean 2c deviation index (M2cDI)
The 2cDI is defined according to Bocking et al.
(40) as the ratio between the sum of the squares of
the differences between the DNA values of individ-
ual cells (Ci) and the 2c value and the number of
cells measured (N):
1
Rotighly, the 2cDI reflects the variation of the nu-
clear DNA around ihe 2c value within one case.
The standard deviation of the 2cDI was alscj calcu-
lated (S2cDI). In addition, the modified mean and
standard deviation of the 2cDI (M2cDIM, S2cDIM)
were computed omitting all nuclei with DNA val-
ues being integer-valued exponents of 2c ±12.5%.
Thus euploid-polyploid cells are not taken into
account. A value of 12.5% was considered as the
maximum error of meastirement (40).
5c exceeding rate (5cER)
The 5cER is defined according to Bocking et al.
(40) as the percentage of cells with a DNA content
eqtial or more than 5c. Since enploid-polyploid
cells should not contribute H) the 5cER, cells with
DNA values which are integer valued exponents of
2c ± 12.5% are not taken intcj account. Thtis tbe
5cER measures only clearly aneuploid cells.
MAREA: Mean value of the nuclear area within
one case.
SAREA: Standard deviation of the nuclear area
within one case.
MDNA/ SDNA: Mean and standard deviation of
the DNA values within one case omitting nuclei
with DNA values being integer-valtied exponents
of 2c ± 12.5% .
Perc 80, Fere 90, Perc 95: 8()th/90th/95tli peicen-
tiles of the DNA histogram.
Statistical evaluation
Statistical evaluation of the feattires analyzed was
performed with the linear discriminant analysis
program 7M of the BMDP package (41). The relia-
bility of multivariate analysis was assessed by jack-
knife testing. This techniqtie performs a reclassifi-
cation with the same classification matrix, but with-
olding one ca.se. For significance of F values a p <
0.0001 was required.
Diagnostic sensitivity, specificity, and efficiency
of the features analyzed were determined using
formulas as follows:
Diagnostic sensitivity = TIV(TP + FN) x 100;
diagnostic specificity = TN/(TN + FP) x 100;
diagnostic efliciency = (TN + TP)/(TN + TP + FN +
FP) X 100;
whereby TP = true positive, TN = true negative, FP
= false positive, FN = false negative restilts Ibr ma-
lignancy.
The reprodticibility of DNA meastirements was
tested by demonstration of the different ploidy
peaks in rat liver imprints.
Resuits
Univariate analysis
Twelve different morphometric and DNA cytomet-
ric feattires were examined in each of the 63 cases.
As shown in Table 2, wbicli is based on 68 400
individual measurements in MN and MM, nuclei of
MN had lower values than nuclei of MM for all
criteria. Univariate analysis revealed significanl dif-
ferences between MN and MM in 5 cjf 12 criteria
(for p < 0.0001 an F-value higher than 15 is re-
cjtiired, see Fable 2). The featuies wliicb discrimi-
nated between MN and MM most reliably were (in
order of decreasing F-values): SAREA, PERC^ HO,
PERC90, MARKA, PERC95, M2cDl, S2cDI. Using
10
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Tabie 3. Sfepwise mulfivariate analysis: Seiected feafures and their F-vaiues for
discrimination of benign and maiignant melanocytic lesions at the end of
multivariate analysis
Seiected variables F-vaiues Other variables F-values
SAREA
MDNA
Perc 95
12.8
3.4
7.4
MAREA
M2CDI
S2CDI
SDNA
Perc80
Perc90
5CER
M2CDIM
S2CDiM
0.0
0.1
0.1
2.1
0.9
0.6
0.1
0.0
0.3
For expianation of variables see materials and methods.
SAREA alone 82.5% of the melanocytic lesions
cotild be ccjrrectly diagiic:)sed.
Multivariate analysis
Many of the variables shown in fable 2 measure
similar characteristics and therefore they might be
cc:)rielated. To analyze possible correlations and tc:)
find the most appropriate combination of features
for the differential diagnosis between MN and
MM, stepwise nuiltivariatc analysis was performed.
Correct classification of 89.5% of the cases ana-
lyzed was achieved using a eombination of three
features: SAREA, MDNA\ PERC95, which were in-
cluded ill the first three steps of multivariate analy-
sis (see Table 3 and Fig. 2). Tbe corresponding
sensitivities and specificities were 89.7% and
88.9%, respectively. Due to the correlation be-
tween some of the featuies, some variables present-
ing with high F-values in univariale analysis were
less helpful in multivariate analysis, as indicated by
STEPWISE LINEAR DISCRIMINANT ANALYSIS
Melanoma versus Nevi
90 -
89
S8
87
86
85
84
83
82
81
SAREA PERC9.5 MDNAM
Fig. 2. Slepwisc" linear ctiscriniinanl analysi.s tor ctifteienlialion
between nialignanl inelaiionia and luelanocylic nevi. U.sing the
lliree feaunes — stanclarct ctevialiou of nuclear area (SARt'"A),
m e a n D N A v a l u e ( M D N A ) , a n r l O.^illi | ) e i c e n t i l e o l D N A c l i su i -
buUon (in':RC9.5) - 89..5% of itie MM anct MN la.ses could IK-
correctly diagno.sed.
Table 4.
Selected
SAREA
MDNA
PERC95
Coefficients
Variables
for calculation of the canonical variable
Coefficients
-0,08918
0,55689
-1.58452
For explanation of variables see materials and methods.
their low F-vahies in Table 3 (MAREA, PERC80,
PERC90). In contrast, MDNA was incltided in mul-
tivariate analysis althotigh presenting a low F-value
in univariate analysis. Classification rate in mtiltiva-
riate analysis was 7% higher than in univariate
analysis.
At the end of mullivariate analysis the three
feattires selected can be summarized with a linear
eqtiation to a new variable termed canonical varia-
ble (CANVAR). T h e coefficients for this eqtiation,
given in Table 4, were de te rmined in the BMDP7M
program (41). According to its definition, the
2.0-
1.0-
n 77
-1.0-
1 70
-2.0-
•
•
•
1
• •
• •
•
•
•••
•
•
• •••
•
•
•i
•
• •
•
• ••
•
•
•
t •
•
•
1 1
MELANOCYTIC MAUGNANT DYSPLASTIC
NEVUS MELANOMA NEVUS
/•/V. J. U.sing a ihie.shotd for llie CANN'/VR ol -0.77, 91.2% of
the MM and MN could he differenliaied. Four of the DN were
found ill the benign range, wherea.s 2 were located within the
malignant lesions.
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MELANOCYTIC NEVUS (JUNCTIONAL TYPE)
I 6
Relative DNA conlcnt
DYSPLASTIC NEVUS
F=
(JUNCTIONAL TYPE)
2 4 6
KcIoHve DNA content
SUPERFICIAL SPREADING MALIGNANT MELANOMA
(Uvel 111. 0.8 mm)
METASTASIS OF MALIGNANT MELANOMA
f% f% f l
Relative DNA content
4 6
Relative DNA conlent
Fig. 4. Four typical patterns of DNA histogtains could he found in this sludy:
a: Example lor type I, displaying a distribution with one hif^h peak at 2c and a small peak at 'lc with less than .5% of the nuclei with
DNA values between ?>.bc and 4..5c DNA (type I). Type I was found in 83.3% of the MN. Type II showing bimodal distribution with a
high peak (more ihan 10% of the nuclei) at 4c in addition to the 2c peak. Type II was calculated in 3 cases of fVTM (not shown in this
figure).
b; Type HI presents with a bimodal distribution similar lo type II, but with more thati b% of the nuclei in the gap between 2.2.'5C and
3..5c (S-phase cells and aneuploid cells). Type III was Ibtind most frequently in DN (83.3%) and MM (32.3%).
c, d: Type IV is characterized by at least 1% of the cells wiUi aneuploid DNA values > .5c . Type IV could be obsci-ved in 3.5% of the
MM (12 cases) and 100% of the MM metasta.ses. In conUast. only 1 of 18 MN (.5%) showed this DNA dislribntion pattern.
CANVAR has the same discriminant power as the
three selected features together. Using the coeffi-
cients for calculation of the CANVAR, for each case
a new individttal canonical value can be calculated
from the values of SAREA, MDNA, and PERC95.
The higher this CANVAR valtie, the higher is the
chance of malignancy. In our sludy the CANVAR
for MN ranged from -2.20 to -0.35 (mean value
-1.52), for primary MM from -1.65 to 2.30 (mean
value 0.55). DN displayed CANVAR between -1.99
and 0.0 (mean value -1.04), metastases of MM
between 0.38 and 2.73 (mean value 1.63).
Using a threshold provided by multivariate anal-
ysis 51 out of 57 cases (89.5%) could be correctly
differentiated (see Fig. 3). By applying -0.77 as
thre.shold one cotild argue that even 52 out of 57
cases (91.2%) could be separated. However, tbis
was not confirmed by statistical analysis, since the
difference between the benign and malignant
cases at this threshold was too small for a safe
distinction. In Fig. 3, CANVAR values above -0.77
were found almost exclusively in MM and all cases
of MN were below -0.13. Therefore, in otir scale a
CANVAR higher than -0.13 can be considered as
proof of malignancy. No MM displayed a CANVAR
below-1.79.
DNA histograms
The four classical types of DNA histograms (36)
could also be found in imprints of melanocytic
lesions (see Fig. 4a-d). Fig. 4a depicts a distribu-
tion with one high peak at 2c and a small peak at
4c with less than 5% of tbe nuclei with DNA values
between 3.5c and 4.5c DNA (type I). This type was
most freqtiently found in benign MN: 83.3% (15
ca.ses) of MN, but also 23.5% (8 cases) of MM
showed this pattern.
Type II (not shown here) depicts a bimodal dis-
tribution with a high peak (more than 10% of the
nticlei) at 4c in adchtion to the 2c peak. It was seen
in 3 cases of MM.
A bimodal distribtition similar to type II, but
with more than 5% of the nuclei in the gap be-
tween 2.25c and 3.5c (S-phase cells and aneuploid
cells) is typical for type III. It was found in 2 of 18
MN ( 11%), 5 of 6 (83.3%) DN, and in 11 of 34
MM (32.3%) (see Fig. 4b).
The type fV histogram (.see Fig. 4c, d), character-
ized by the presence of at least 1% aneuploid cells
having DNA values >5c, could be observed in 35%
of tbc' MM (12 cases) and 100% of the MM meta-
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stases. In contrast, only 1 of 18 MN (5%) showed
this DNA distribution pattern.
Classification of dysplastic nevi (DN)
Fig. 3 shows the classification of DN using the
CANVAR values calculated for discrimination be-
tween MM and MN. In one case with 0.0 the CAN-
VAR value was clearly in the range of MM. In an
additional case, a CANVAR value of -0.61 was
found, which is slightly higher than -0.77, the
threshold for the separation between MM and MN.
Three cases displayed CAK\^ A1^ valties in a /one in
which most of the cases were benign and only a few
were malignant. One case had a CANVAR value
within a zone with MN only.
Discussion
The most important result of this cytometric study
was that melanocytic nevi (MN) and malignant
melanomas (MM) could be differentiated on im-
prints witli an efficiency of 89.5% using three fea-
tures, the standard deviation of nuclear area
(SAl^A), the mean value of DNA content of the
nuclei (MDNA), and die 95th percentile of DNA
distribution (PERC95). The sensitivity and specific-
ity attained were 89.7% and 88.9%, respectively.
The diagnostic efficiency of 89.5% in this sttidy is
higher than in 4 otit of 6 previotis DNA cytometric
investigations on sections, in which between 76.1 %
and about 100% of the cases (mean value 87.5%)
were correctly cla.ssified (16, 29, 32, 33, 34, 35).
The different classification rates in those studies
can be explained by different methods of feattire
extraction, data analysis, definition of aneuploidy,
number of cases of each eategoiy analyzed, selec-
tion of tumors for analysis, and cell sampling strat-
egies. To our knowledge, using FC, only Chi et al.
(36) found aneuploidy in all of 20 MM and could
therefore clearly distinguish them from benign
nevi and Spitz nevi. Hc^wever, all of tbeir jDrobes
were taken from advanced nodular lesions being
unequivocal for bistopalbologists.
It is impressive that the efficiency of di.scrimi-
nation between MM and MN in imprint specimens
using IA is equal to or even higher than in studies
using .sections for DNA measurements with IA (29,
32, 35) or CP (33). It can be spectilated that on
imprint specimens DNA features are especially
helpful, because the whole nticletis can always be
definitely measured, which is not possible on sec-
tions. Since IA of imprints of melanocytic lesions
reveal resvilts at least of the same efficiency as of
sections, imprints can be recommended for future
investigations for two reasc:)ns: a) A rapid prep-
aration after excision withotit loss of potentially
impc:)rtant tissue is possible, b) Time-saving auto-
matic detection of the borders with fully automatic
feature-analysis can be performed. Therefore the
meastirement of 100 melanocytic nticlei can be
done in less than 30 min. Nevertheless, also ar-
chival material can be analyzed, since imprints can
also be obtained from paraffin blocks, although
the probability of detecting aneuploid nuclei is
more likely on imprints of fresh than of paraffin-
embedded ti.sstie (42). The interesting results ob-
tained here on imprints of MM and MN by IA were
in agreement with those of a cytophotometric
study of Bergman (16). He cotild also differentiate
between MM and MN in 89.7% of the cases. How-
ever, CP is mtich more time-consuming than IA
and morphometric featuies cannot be determined
simultaneously (23, 24).
A drawback to the analysis of Feulgen-stained
imprint specimens is, that it is not definitely pos-
sible to discriminate tumor cells from other not
interesting cells, e.g. keratinocytes. However, anal-
yses of May-Giuuwald stained imprints of melan-
ocytic lesions disclosed that keratinocytes were not
abundant, since the adherence of non-ttimor cells
in the tissue is much higher than of melanc:)cytic
cells. Moreover, if keratinocytes are also measured,
these diploid cells do not cause false positive re-
sults.
1 he tendency towards higher proliferation and
appearance of polyploid and aneuploid eells in
malignant melanocytic tumors is documented by
the finding of four different types of DNA his-
tograms in our study (Fig. 4). The results obtained
from the ctirrently controversially discussed group
of DN (43-46) also indicate an increased prolifer-
ation of melanocytes within this grotip. However,
true aneuploidy was not detected in DN, which is
in agreement with the data of a recent cytometric
study of 38 cases fulfilling the histologic criteria of
DN (47). Five of 6 lesions presented a type III
histogram, displaying a bimodal distribution with
more than 5% of the nuclei in the space between
2.25c and 3.5c, probably S-pha.se cells. In addition,
also the CANVAR vahies of DN supported the in-
termediate position of dysplastic nevi in the transi-
tion zone between benign and malignant, as al-
ready speculated (16, 31, 35, 30). However DN
could not he separated from MM and MN by mor-
phometric and cytometric criteria as a distinct en-
tity.
Thousands of cells can also be analyzed within
niiiuites by FC (22), which was frequenUy used for
DNA measurements of melanocytic lesions (25-
30). However, in FC, the interpretation of hyper-
teli aploid signals of low freqtiency is diffictilt due
to the high rate of false alarms caused by aggre-
gated cells (48). Atitofluorescence c:)f melanocytic
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nuclei and destroyed cells might also contribute to
bias and explains the limited diagnostic efficiency
of FC compared to IA. IA permits visual exam-
ination of each cell and interactive rejection of
clumped and destroyed nuclei is pcjssible. Thus,
diagnostically important cells with high DNA val-
ues strongly influencing the value for the 95th
percentile and mean DNA value can be detected
with high accuracy (24). In MM, FC seems to be
more tiseftil for prognostic evaluation (49, 50).
Differentiation between MM and MN was also
performed in light microscopy applying pure mor-
phometric and stereologic analyses (5, 6, 51). The
importance of morphometric data for the discrimi-
nation between MM and MN can also be seen in
this sttidy, becatise of the classification rate of
82.5% for SAREA, which was the best criterion in
univariate analysis. However, classification rates
cotild be increased to 89.5%, if DNA cytometric
feattires were included.
IA, the most general approach lo cell analysis, is
an adequate method fcjr extracting a multittide ol
features with high accuracy (24). Moreover, IA
allows also the evaluation of a variety of chromatin
feattires, e.g. the amount of eti- and heterochroma-
tin, chromatin homogeneity, and chromatin aggre-
gations (21, 24). In a recent ultrastructural study
applying 34 different morphometric and chroma-
tin f^ teattiies, all of the cases could be correctly
cla.ssified as MN or MM dtie to the characterization
of markedly atypical cells (MA(]S) (52). MACS
were selected by eight different features describing
the amount of eu- and beterochromatin, chroma-
tin aggregations and nuclear morphology. There-
fore it seems to be possible that the diagnostic
efficiency can be further improved by chromatin
texture analysis, as was also recently demonstrated
in a multiparametric study of Fleming and Fried-
man (53) . Also the developments in artificial in-
telligence involving neural networks may facilitate
the diagnostic process in the future (54).
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